Central Nervous System Stimulant Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (amphetamine, caffeine, nicotine, methamphetamine, other); Application (ADHD, sleeping disorder, depression, obesity, respiratory depression); End Use (Children, Adult), and Geography

Report Code: TIPRE00014224 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Medicines for the central nervous system stimulate the physical and mental processes of the body. The stimulant has a chemical structure identical to monoamine neurotransmitters. These drugs are used in certain medical cases. In stimulants there are different ways of behaving. More than ever, the amounts of the dopamine-induced neurotransmitter that promote brain activity are enhanced by stimulant drugs. CNS stimulants include narcoleptic, neonatal apnea, lethargy, and other drugs. Stimulants are sometimes used as drugs, but are often mis-consumed or unprescribed.

MARKET DYNAMICS

The rising numbers of CNS disorders such as sleep apnea, narcolepsy and hyperactivity of attention deficit boost worldwide sales and uses of soothing drugs in the central nervous system. The growth and functioning of an infant is impaired by a hyperactive condition with concentration deficit marked by carelessness, hyperactivity and impulsivity. The hyperactivity condition of treatment neglect is typically common in children and adolescents. Narcolepsy, an anxious disease of the body, is often characterised by prolonged and persistent disturbances of body during the day.

MARKET SCOPE

The "Central Nervous System Stimulant Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Central Nervous System Stimulant Drugs market with detailed market segmentation by product type, and application. The Central Nervous System Stimulant Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Central Nervous System Stimulant Drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Central Nervous System Stimulant Drugs market is segmented on the basis of type, application and end use. Based on type, the market is segmented as amphetamine, caffeine, nicotine, methamphetamine, and other. On the basis of application, the market is categorized as ADHD, sleeping disorder, depression, obesity, respiratory depression. On the basis of end use the market is characterized by children, adults.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Central Nervous System Stimulant Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Central Nervous System Stimulant Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Central Nervous System Stimulant Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Central Nervous System Stimulant Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Central Nervous System Stimulant Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Central Nervous System Stimulant Drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Central Nervous System Stimulant Drugs in the global market. Below mentioned is the list of few companies engaged in the Central Nervous System Stimulant Drugs market.

The report also includes the profiles of key players in Central Nervous System Stimulant Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GlaxoSmithKline Plc
  •  Johnson & Johnson Services Inc.
  •  Novartis AG (NYSE: NVS)
  •  Pfizer Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  Astellas Pharma
  •  Biogen
  •  Celltech
  •  Eli Lilly and Company
  •  Roche

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Central Nervous System Stimulant Drugs Market - By Type
1.3.2 Central Nervous System Stimulant Drugs Market - By Application
1.3.3 Central Nervous System Stimulant Drugs Market - By End Use
1.3.4 Central Nervous System Stimulant Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS - GLOBAL MARKET OVERVIEW
6.2. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AMPHETAMINE
7.3.1. Overview
7.3.2. amphetamine Market Forecast and Analysis
7.4. CAFFEINE
7.4.1. Overview
7.4.2. caffeine Market Forecast and Analysis
7.5. NICOTINE
7.5.1. Overview
7.5.2. nicotine Market Forecast and Analysis
7.6. METHAMPHETAMINE
7.6.1. Overview
7.6.2. methamphetamine Market Forecast and Analysis
7.7. OTHER
7.7.1. Overview
7.7.2. other Market Forecast and Analysis
8. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ADHD
8.3.1. Overview
8.3.2. ADHD Market Forecast and Analysis
8.4. SLEEPING DISORDER
8.4.1. Overview
8.4.2. sleeping disorder Market Forecast and Analysis
8.5. DEPRESSION
8.5.1. Overview
8.5.2. depression Market Forecast and Analysis
8.6. OBESITY
8.6.1. Overview
8.6.2. obesity Market Forecast and Analysis
8.7. RESPIRATORY DEPRESSION
8.7.1. Overview
8.7.2. respiratory depression Market Forecast and Analysis
9. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. CHILDREN
9.3.1. Overview
9.3.2. Children Market Forecast and Analysis
9.4. ADULT
9.4.1. Overview
9.4.2. Adult Market Forecast and Analysis
10. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Central Nervous System Stimulant Drugs Market Overview
10.1.2 North America Central Nervous System Stimulant Drugs Market Forecasts and Analysis
10.1.3 North America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By End Use
10.1.6 North America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Central Nervous System Stimulant Drugs Market
10.1.6.1.1 United States Central Nervous System Stimulant Drugs Market by Type
10.1.6.1.2 United States Central Nervous System Stimulant Drugs Market by Application
10.1.6.1.3 United States Central Nervous System Stimulant Drugs Market by End Use
10.1.6.2 Canada Central Nervous System Stimulant Drugs Market
10.1.6.2.1 Canada Central Nervous System Stimulant Drugs Market by Type
10.1.6.2.2 Canada Central Nervous System Stimulant Drugs Market by Application
10.1.6.2.3 Canada Central Nervous System Stimulant Drugs Market by End Use
10.1.6.3 Mexico Central Nervous System Stimulant Drugs Market
10.1.6.3.1 Mexico Central Nervous System Stimulant Drugs Market by Type
10.1.6.3.2 Mexico Central Nervous System Stimulant Drugs Market by Application
10.1.6.3.3 Mexico Central Nervous System Stimulant Drugs Market by End Use
10.2. EUROPE
10.2.1 Europe Central Nervous System Stimulant Drugs Market Overview
10.2.2 Europe Central Nervous System Stimulant Drugs Market Forecasts and Analysis
10.2.3 Europe Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By End Use
10.2.6 Europe Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Central Nervous System Stimulant Drugs Market
10.2.6.1.1 Germany Central Nervous System Stimulant Drugs Market by Type
10.2.6.1.2 Germany Central Nervous System Stimulant Drugs Market by Application
10.2.6.1.3 Germany Central Nervous System Stimulant Drugs Market by End Use
10.2.6.2 France Central Nervous System Stimulant Drugs Market
10.2.6.2.1 France Central Nervous System Stimulant Drugs Market by Type
10.2.6.2.2 France Central Nervous System Stimulant Drugs Market by Application
10.2.6.2.3 France Central Nervous System Stimulant Drugs Market by End Use
10.2.6.3 Italy Central Nervous System Stimulant Drugs Market
10.2.6.3.1 Italy Central Nervous System Stimulant Drugs Market by Type
10.2.6.3.2 Italy Central Nervous System Stimulant Drugs Market by Application
10.2.6.3.3 Italy Central Nervous System Stimulant Drugs Market by End Use
10.2.6.4 Spain Central Nervous System Stimulant Drugs Market
10.2.6.4.1 Spain Central Nervous System Stimulant Drugs Market by Type
10.2.6.4.2 Spain Central Nervous System Stimulant Drugs Market by Application
10.2.6.4.3 Spain Central Nervous System Stimulant Drugs Market by End Use
10.2.6.5 United Kingdom Central Nervous System Stimulant Drugs Market
10.2.6.5.1 United Kingdom Central Nervous System Stimulant Drugs Market by Type
10.2.6.5.2 United Kingdom Central Nervous System Stimulant Drugs Market by Application
10.2.6.5.3 United Kingdom Central Nervous System Stimulant Drugs Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Central Nervous System Stimulant Drugs Market Overview
10.3.2 Asia-Pacific Central Nervous System Stimulant Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Central Nervous System Stimulant Drugs Market
10.3.6.1.1 Australia Central Nervous System Stimulant Drugs Market by Type
10.3.6.1.2 Australia Central Nervous System Stimulant Drugs Market by Application
10.3.6.1.3 Australia Central Nervous System Stimulant Drugs Market by End Use
10.3.6.2 China Central Nervous System Stimulant Drugs Market
10.3.6.2.1 China Central Nervous System Stimulant Drugs Market by Type
10.3.6.2.2 China Central Nervous System Stimulant Drugs Market by Application
10.3.6.2.3 China Central Nervous System Stimulant Drugs Market by End Use
10.3.6.3 India Central Nervous System Stimulant Drugs Market
10.3.6.3.1 India Central Nervous System Stimulant Drugs Market by Type
10.3.6.3.2 India Central Nervous System Stimulant Drugs Market by Application
10.3.6.3.3 India Central Nervous System Stimulant Drugs Market by End Use
10.3.6.4 Japan Central Nervous System Stimulant Drugs Market
10.3.6.4.1 Japan Central Nervous System Stimulant Drugs Market by Type
10.3.6.4.2 Japan Central Nervous System Stimulant Drugs Market by Application
10.3.6.4.3 Japan Central Nervous System Stimulant Drugs Market by End Use
10.3.6.5 South Korea Central Nervous System Stimulant Drugs Market
10.3.6.5.1 South Korea Central Nervous System Stimulant Drugs Market by Type
10.3.6.5.2 South Korea Central Nervous System Stimulant Drugs Market by Application
10.3.6.5.3 South Korea Central Nervous System Stimulant Drugs Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Central Nervous System Stimulant Drugs Market Overview
10.4.2 Middle East and Africa Central Nervous System Stimulant Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Central Nervous System Stimulant Drugs Market
10.4.6.1.1 South Africa Central Nervous System Stimulant Drugs Market by Type
10.4.6.1.2 South Africa Central Nervous System Stimulant Drugs Market by Application
10.4.6.1.3 South Africa Central Nervous System Stimulant Drugs Market by End Use
10.4.6.2 Saudi Arabia Central Nervous System Stimulant Drugs Market
10.4.6.2.1 Saudi Arabia Central Nervous System Stimulant Drugs Market by Type
10.4.6.2.2 Saudi Arabia Central Nervous System Stimulant Drugs Market by Application
10.4.6.2.3 Saudi Arabia Central Nervous System Stimulant Drugs Market by End Use
10.4.6.3 U.A.E Central Nervous System Stimulant Drugs Market
10.4.6.3.1 U.A.E Central Nervous System Stimulant Drugs Market by Type
10.4.6.3.2 U.A.E Central Nervous System Stimulant Drugs Market by Application
10.4.6.3.3 U.A.E Central Nervous System Stimulant Drugs Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Central Nervous System Stimulant Drugs Market Overview
10.5.2 South and Central America Central Nervous System Stimulant Drugs Market Forecasts and Analysis
10.5.3 South and Central America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Central Nervous System Stimulant Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Central Nervous System Stimulant Drugs Market
10.5.6.1.1 Brazil Central Nervous System Stimulant Drugs Market by Type
10.5.6.1.2 Brazil Central Nervous System Stimulant Drugs Market by Application
10.5.6.1.3 Brazil Central Nervous System Stimulant Drugs Market by End Use
10.5.6.2 Argentina Central Nervous System Stimulant Drugs Market
10.5.6.2.1 Argentina Central Nervous System Stimulant Drugs Market by Type
10.5.6.2.2 Argentina Central Nervous System Stimulant Drugs Market by Application
10.5.6.2.3 Argentina Central Nervous System Stimulant Drugs Market by End Use
10.5.6.3 Chile Central Nervous System Stimulant Drugs Market
10.5.6.3.1 Chile Central Nervous System Stimulant Drugs Market by Type
10.5.6.3.2 Chile Central Nervous System Stimulant Drugs Market by Application
10.5.6.3.3 Chile Central Nervous System Stimulant Drugs Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CENTRAL NERVOUS SYSTEM STIMULANT DRUGS MARKET, KEY COMPANY PROFILES
13.1. GLAXOSMITHKLINE PLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. JOHNSON AND JOHNSON SERVICES INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. 3NOVARTIS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PFIZER INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ASTELLAS PHARMA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BIOGEN
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CELLTECH
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ELI LILLY AND COMPANY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROCHE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline Plc
2. Johnson & Johnson Services Inc.
3. Novartis AG (NYSE: NVS)
4. Pfizer Inc.
5. Teva Pharmaceutical Industries Ltd.
6. Astellas Pharma
7. Biogen
8. Celltech
9. Eli Lilly and Company
10. Roche
TIPRE00014224
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking